Ross, A., Donachie, P., Sallam, A., Stratton, I., Mohamed, Q., Scanlon, P., . . . Johnston, R. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
Cita Chicago (17th ed.)Ross, A., P. Donachie, A. Sallam, I. Stratton, Q. Mohamed, P. Scanlon, J. Kirkpatrick, i R. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
Cita MLA (9th ed.)Ross, A., et al. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
Atenció: Aquestes cites poden no estar 100% correctes.